2750638-94-7
Chemical Structure
CDK7-IN-12
- CAS No.: 2750638-94-7
- Formula:C20H19F3N6
- Molecular Weight:400.40
IUPAC Name: (S)-6-(1H-indol-3-yl)-N-(piperidin-3-yl)-5-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-amine
InChIKey: ZMUIQHLNZCFNDG-LBPRGKRZSA-N
SMILES: FC(C1=C(C2=CNC3=C2C=CC=C3)N=C(N[C@@H]4CNCCC4)C5=NC=CN51)(F)F
Biological Activity: CDK7-IN-12 is a potent inhibitor of CDK7. CDK7-IN-12 plays a key role in transcriptional regulation and cell cycle regulation. CDK7-IN-12 effectively inhibit malignant tumor proliferation in vitro and in vivo. CDK7-IN-12 has the potential for the research of cancer disease (extracted from patent WO2021249417A1, compound 43)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDK7-IN-12 | CDK7-IN-12 is a potent inhibitor of CDK7. CDK7-IN-12 plays a key role in transcriptional regulation and cell cycle regulation. CDK7-IN-12 effectively inhibit malignant tumor proliferation in vitro and in vivo. CDK7-IN-12 has the potential for the research of cancer disease (extracted from patent WO2021249417A1, compound 43). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
